Valerie Morisset
Equibles does not estimate personal net worth.
About Valerie Morisset
Climb Bio, Inc. reported in an 8-K filed August 27, 2024 that Valerie Morisset was terminated as Executive Vice President, Research and Development and Chief Scientific Officer, effective August 23, 2024. The proxy statement of Climb Bio, Inc. reports total compensation of $2,235,295 for Valerie Morisset in fiscal 2024, including a base salary of $358,066. Disclosed compensation is on record for 5 fiscal years.
“Dr. Morisset's employment ended on August 23, 2024 (the "Separation Date").”
Affiliation history
-
Climb Bio, Inc. (CLYM)
Proxy statement
Start not stated–2024-08-23
Company network
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Climb Bio, Inc. (CLYM) | Former Executive Vice President, Research and Development and Chief Scientific Officer | $358,066 | $2,235,295 |
| 2023 | Climb Bio, Inc. (CLYM) | Former Executive Vice President, Research and Development and Chief Scientific Officer | $510,853 | $1,077,620 |
| 2022 | Climb Bio, Inc. (CLYM) | — | $399,916 | $1,989,782 |
| 2021 | Climb Bio, Inc. (CLYM) | — | $347,133 | $2,525,721 |
| 2020 | Climb Bio, Inc. (CLYM) | — | $324,128 | $905,460 |